NCT06221228

Flipped Classroom Approach in Continuous Ambulatory Peritoneal Dialysis Training

Flipped Classroom Approach in Continuous Ambulatory Peritoneal Dialysis Training: Protocol
The Hong Kong Polytechnic University·ClinicalTrials.gov·behavioralNot yet recruiting
View on ClinicalTrials.gov
Study focus
Disease/Condition
Chronic Kidney Disease
Drug/Device/Intervention
Audio-visual assisted Flipped Classroom (FC) CAPD Training Programme
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
The Hong Kong Polytechnic University
Location
Hung Hom, China
Timeline & enrollment
Phase
N/A
Start date
Sep 01, 2024
End date
Sep 01, 2026
Enrollment
60 participants
Primary outcome

Peritoneal Dialysis Psychomotor Skill Competency Checklist

Summary

The goal of this single-blinded randomized controlled trial is to evaluate the effectiveness
 of an educational intervention for patient self-management and successful renal replacement
 therapy in Chronic Kidney Disease (CKD) patients.
 
 The main question it aims to answer is whether the flipped class pedagogy in delivering the
 pre-dialysis program to CKD patients is effective.
 
 Participants will undergo a week-long intervention consisting of pre-class instructional
 videos, self-study tutorials, face-to-face sessions, and take-home exercises, and will be
 compared to those receiving the conventional educational course.

ICD-10 classifications
Chronic kidney diseaseChronic kidney disease, unspecifiedChronic kidney disease, stage 1Chronic kidney disease, stage 4Chronic kidney disease, stage 2
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06221228
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06221228 through Pure Global AI's free database. This phase not specified trial is sponsored by The Hong Kong Polytechnic University and is currently Not yet recruiting. The study focuses on Chronic Kidney Disease. Target enrollment is 60 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.